Physician profile
Christopher Frederick Ketcham
NPI 1780098780
$1,648.50
in general payments reported to CMS, 2019-2025
19 companies · $314 in 2025
The $314 reported for 2025 was more than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $352 · 2020: $171 · 2021: $145 · 2022: $234 · 2023: $349 · 2024: $83.98 · 2025: $314.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $747.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $746.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ipsen Biopharmaceuticals, INC | $444.72 | 2019-2025 | Dysport |
| Allergan, INC. | $291.41 | 2019-2022 | |
| Abbvie INC. | $180.94 | 2023-2025 | |
| Avanir Pharmaceuticals, INC. | $119.74 | 2019-2022 | |
| Merz North America, INC. | $113.79 | 2019-2020 | |
| Merz Pharmaceuticals, LLC | $91.75 | 2021-2024 | Xeomin |
| Amgen INC. | $86.42 | 2019-2023 | Otezla, Repatha |
| Stryker Corporation | $84.18 | 2020-2025 | Mako |
| Radius Health, INC. | $75.10 | 2022-2023 | Tymlos |
| Alphatec Spine, INC | $40.34 | 2022 | |
| Vifor Pharma, INC. | $16.16 | 2019 | |
| Saol Therapeutics INC. | $16.11 | 2019 | |
| Genentech USA, INC. | $15.53 | 2019 | |
| Sanofi Pasteur INC. | $13.32 | 2019 | |
| Pfizer INC. | $13.00 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neos Therapeutics, LP | $12.71 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $11.20 | 2019 | |
| Merck Sharp & Dohme LLC | $11.18 | 2019 | |
| Novo Nordisk INC | $10.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Ketcham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.